DekaBank Deutsche Girozentrale »

Xortx Therapeutics shares owned by DekaBank Deutsche Girozentrale

Quarter-by-quarter ownership of Xortx Therapeutics (XRTX) shares owned by DekaBank Deutsche Girozentrale from 13F filings

Historical chart of DekaBank Deutsche Girozentrale investment in Xortx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xortx Therapeutics held by DekaBank Deutsche Girozentrale consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xortx Therapeutics by DekaBank Deutsche Girozentrale

Quarter filed Position value Share count Share price at filing
2023-12-31 $163M 2.8M 58.15

More positions owned by DekaBank Deutsche Girozentrale

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Apple (AAPL)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Procter & Gamble Company (PG)
Merck & Co (MRK)
Johnson & Johnson (JNJ)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Mastercard Incorporated Cl A (MA)
Accenture Plc Ireland Shs Class A (ACN)
Abbvie (ABBV)

View all positions for DekaBank Deutsche Girozentrale

Top funds holding Xortx Therapeutics

Advisor Group Holdings
Royal Bank of Canada
Hartland & Co

View all funds holding Xortx Therapeutics